3

PRIMARY DOCUMENT

Company: ATOSSA THERAPEUTICS, INC.
Filed: October 15, 2013
Period of Report: October 10, 2013
Accession Number: 0000904454-13-001116

View Document ↗ View on SEC.gov ↗